0001209191-22-059262.txt : 20221201
0001209191-22-059262.hdr.sgml : 20221201
20221201204737
ACCESSION NUMBER: 0001209191-22-059262
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221129
FILED AS OF DATE: 20221201
DATE AS OF CHANGE: 20221201
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Goldberg Jeff Marc
CENTRAL INDEX KEY: 0001703061
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37722
FILM NUMBER: 221440111
MAIL ADDRESS:
STREET 1: C/O AKCEA THERAPEUTICS
STREET 2: 55 CAMBRIDGE PARKWAY, STE 100
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aeglea BioTherapeutics, Inc.
CENTRAL INDEX KEY: 0001636282
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 464312787
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 805 LAS CIMAS PARKWAY
STREET 2: SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78746
BUSINESS PHONE: (512) 942-2935
MAIL ADDRESS:
STREET 1: 805 LAS CIMAS PARKWAY
STREET 2: SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78746
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-11-29
0
0001636282
Aeglea BioTherapeutics, Inc.
AGLE
0001703061
Goldberg Jeff Marc
C/O AEGLEA BIOTHERAPEUTICS, INC.
805 LAS CIMAS PARKWAY, SUITE 100
AUSTIN
TX
1
1
0
0
President and CEO
Employee Stock Option (right to buy)
1.22
2022-11-29
4
A
0
1884838
0.00
A
2032-11-28
Common Stock
1884838
1884838
D
The stock option vests and becomes exercisable as to 1/4 of the total award on November 29, 2023, and an additional 1/48 of the award will vest monthly thereafter until the option is 100% vested on November 29, 2026, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
/s/ James Kastenmayer, by power of attorney
2022-12-01